has opened up avenues to a new HIV treatment as the rates of HIV
diagnosis continues to climb. With its Ontario Drug Benefit Program,
HIV-infected individuals can now use the one-pill-a-day drug
drug has nearly no side effects for most individuals and can quickly
reduce HIV viral load to non-detectable levels, ensuring the virus
isn’t likely to spread.
Leaf Medical Clinical Director Dr. Jason Brunetta was the key
researchers during the clinical trials for Biktavry, and he said the
community’s goal is to bring the viral load of every HIV positive
individual down to non-detectable levels. The hospital is located in
reported that 39 percent of people are HIV positive, making it the
highest in Canada. Based on 2017 data, Toronto is regarded as having
the highest new diagnosis rates and numbers. From 2014 to 2017, there
was a rise in the number of cases. In 2017, there were over 900 new
was a 12 percent increase in the number of new HIV diagnosis from
2013 to 2017. In 2013, the rate of infection was 5.8 percent per
100,000 people. The percentage was to 6.5 percent per 100,000 for the
said it’s a huge deal to offer the new drug on the benefit plan. He
said other HIV drugs failed to pass the formula area the government
Biktarvy has very little side effects, patients must stay on the
medication for a longer period.
said patients are unlikely to continue medication that makes them
sick. And, if a patient misses taking a pill, the virus can overtake
it. He said with more access to the better drug, it would change
their lives completely.
single-day HIV medications made people extremely sick.
who’s been using HIV treatments that caused him to get sick, has
been using Biktarvy for a year and has had no side effects.
50-something-year-old said he loves Biktarvy.
drug is also ideal for older HIV patients to stay on the treatment
without worrying about co-risk factors like bone, cardiac, liver and
According to CATIE medical editor Sean Hosein, Biktarvy is the kind of treatment that allows people to live a healthier life. He said HIV is a chronic disease, and the drug will help them to have better health. And, since the drug is listed under the drug plan, the news is big for HIV-infected individuals and society as a whole.